Biogen Message Board - Msg: 9723820

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 153.64

-2.0%

11:26 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (977)	5/24/1999 2:21:00 PM
From: William Partmann	Read Replies (1) of 1686

Harold: >>Heard that the Merrill Lynch analyst has just included Amevive in his revenue projections for 2001-2002. Estimates worldwide sales will reach $600MM annually<< Merrill said in that report that there is a 2 billion dollar "U.S. market opportunity" for the drug and predicts peak worldwide sales of between $300 and $500 million dollars. Hope this helps. Good luck. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next